RBD3133
Asset
siRNA targeting INHBE to regulate metabolic processes.
- Stage
- Phase 1
- Modality
- Oligonucleotide
- Target
- Lipid and ceramide metabolism
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Obesity
Phase 1, prnewswire.com, 8 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners2
- Evidence for its targets2
- Competitors12
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.